Systematic Review and Meta-analysis: Risk of Post-Operative Complications Associated with Anti-Tumor Necrosis Factor Agents for Crohn''s disease

Systematic Review and Meta-analysis: Risk of Post-Operative Complications Associated with Anti-Tumor Necrosis Factor Agents for Crohn''s disease

碩士 === 臺北醫學大學 === 臨床醫學研究所 === 106

Bibliographic Details
Main Authors:	Yang-Sheng Lin, 林揚笙
Other Authors:	Chiehfeng Chen
Format:	Others
Language:	zh-TW
Published:	2018
Online Access:	http://ndltd.ncl.edu.tw/handle/2z5uw8

Similar Items

Risk factors for recurrence of Crohn's disease requiring surgery in patients receiving post-operative anti-tumor necrosis factor maintenance therapy
by: Toshimitsu Araki, et al.
Published: (2017-01-01)

Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
by: Sakiko Hiraoka, et al.
Published: (2018-01-01)

Tumor necrosis factor-alpha antibodies in fistulizing crohn's disease: An updated systematic review and meta-analysis
by: Pardis Zaboli, et al.
Published: (2017-01-01)

Could Early Anti-Tumor Necrosis Factor Therapy Change the Prognosis of Crohn's Disease?
by: Byong Duk Ye
Published: (2014-10-01)

Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
by: Paulo Gustavo Kotze, et al.
Published: (2017-04-01)

Correlation of serum levels of anti-tumor necrosis factor agents with perianal fistula healing in Crohn’s disease: a narrative review
by: Eron Fabio Miranda, et al.
Published: (2021-07-01)

Impact of anti-TNF agents in postoperative complications in Crohn's disease: a review
by: Mansur Saab, et al.
Published: (2015-04-01)

Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor α Antibodies.
by: Sarah Bamberger, et al.
Published: (2016-01-01)

Long‐term outcomes of anti‐tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease
by: Sudheer K Vuyyuru, et al.
Published: (2021-04-01)

Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis
by: Yunwei Hu, et al.
Published: (2020-06-01)

Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
by: Sudheer K. Vuyyuru, et al.
Published: (2021-06-01)

Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.
by: Siddharth Singh, et al.
Published: (2018-01-01)

Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
by: Yunho Jung
Published: (2020-01-01)

Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn’s disease: the Indian experience
by: Ajit Sood, et al.
Published: (2020-04-01)

Correction: Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.
by: PLOS ONE Staff
Published: (2018-01-01)

Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
by: Rintaro Moroi, et al.
Published: (2019-01-01)

Post-operative Crohn's disease : can non-invasive faecal markers predict post-operative course of Crohn's disease
by: Mohiuddin, Mohhamed Khalid
Published: (2011)

Systematic Review with Network Meta-Analysis: Efficacy of Induction Therapy with a Second Biological Agent in Anti-TNF-Experienced Crohn’s Disease Patients
by: Cristiano Pagnini, et al.
Published: (2018-01-01)

Current management of fistulizing perianal Crohn’s disease based on serum anti-tumor necrosis factor levels and magnetic resonance imaging monitoring
by: Felipe Bernardi Wolker, et al.
Published: (2020-10-01)

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease
by: Tetsuya Ishida, et al.
Published: (2014-01-01)

Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn’s Disease—A Systematic Review and Gene Ontology Analysis
by: Boris Gole, et al.
Published: (2019-05-01)

Amyand's hernia with perforated appendicitis complicated by post-operative bowel Necrosis in an extremely preterm infant
by: Sonal Patel, et al.
Published: (2020-08-01)

Post-Operative Complications and Nipple Necrosis Rates Between Conventional and Robotic Nipple-Sparing Mastectomy
by: Jeea Lee, et al.
Published: (2021-01-01)

Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran population
by: Mark Bounthavong, et al.
Published: (2014-05-01)

Effects of the frailty phenotype on post-operative complications in older surgical patients: a systematic review and meta-analysis
by: Binru Han, et al.
Published: (2019-05-01)

Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease
by: Zaidi D, et al.
Published: (2018-05-01)

Comparison of time until elective intestinal resection regarding previous anti-tumor necrosis factor exposure: a Brazilian study on patients with Crohn's disease
by: Paulo Gustavo Kotze, et al.
Published: (2018-01-01)

Rare post-operative complications of large mediastinal tumor resection
by: Mohsen Mirmohammadsadeghi, et al.
Published: (2015-03-01)

Macronutrient Intake and Risk of Crohn’s Disease: Systematic Review and Dose–Response Meta-Analysis of Epidemiological Studies
by: Lirong Zeng, et al.
Published: (2017-05-01)

Gut Microbiota Profiles and Microbial-Based Therapies in Post-operative Crohn's Disease: A Systematic Review
by: Xiaojun Zhuang, et al.
Published: (2021-01-01)

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis
by: Thorlund K, et al.
Published: (2012-12-01)

Adalimumab: A new tumor necrosis factor antagonist and the treatment of <i>Crohn′s disease</i>
by: Helmy Ahmed, et al.
Published: (2007-01-01)

New Onset, Aggravation and Recurrence of Crohn's Disease upon Treatment with Three Different Tumor Necrosis Factor Inhibitors
by: Jonas Zeitz, et al.
Published: (2015-04-01)

Review: Predicting response to anti-TNF agents for the treatment of Crohn's disease
by: Corey A. Siegel, et al.
Published: (2009-07-01)

Abdominal Surgery in Crohn’s Disease: Risk Factors for Complications
by: Cintia Mayumi Sakurai Kimura, et al.
Published: (2020-10-01)

Prevalence Rates and an Evaluation of Reported Risk Factors for Osteonecrosis (Avascular Necrosis) in Crohn’s Disease
by: Hugh J Freeman, et al.
Published: (2000-01-01)

Association of tumor necrosis factor-α gene polymorphisms and coronary artery disease susceptibility: a systematic review and meta-analysis
by: Rui Huang, et al.
Published: (2020-02-01)

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis [Corrigendum]
by: Thorlund K, et al.
Published: (2014-02-01)

Listeria Rhombencephalitis Complicating Anti-TNF Treatment during an Acute Flare of Crohn’s Colitis
by: L. Stratton, et al.
Published: (2016-01-01)

Efficacy of iron supplementation in patients with inflammatory bowel disease treated with anti-tumor necrosis factor-alpha agents
by: Su Young Kim, et al.
Published: (2020-09-01)